Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Debt to Equity: 2021-2024

Historic Debt to Equity for LifeStance Health (LFST) over the last 4 years, with FY2024 value amounting to $0.19.

  • LifeStance Health's Debt to Equity fell 788.68% to $0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.18, marking a year-over-year decrease of 788.68%. This contributed to the annual value of $0.19 for FY2024, which is 416.75% down from last year.
  • Per LifeStance Health's latest filing, its Debt to Equity stood at $0.19 for FY2024, which was down 416.75% from $0.2 recorded in FY2023.
  • LifeStance Health's Debt to Equity's 5-year high stood at $0.2 during FY2023, with a 5-year trough of $0.11 in FY2021.
  • For the 4-year period, LifeStance Health's Debt to Equity averaged around $0.17, with its median value being $0.18 (2022).
  • In the last 5 years, LifeStance Health's Debt to Equity skyrocketed by 4289.95% in 2022 and then tumbled by 416.75% in 2024.
  • LifeStance Health's Debt to Equity (Annual) stood at $0.11 in 2021, then surged by 42.9% to $0.16 in 2022, then grew by 27.24% to $0.2 in 2023, then dropped by 4.17% to $0.19 in 2024.
  • Its Debt to Equity was $0.19 in FY2024, compared to $0.2 in FY2023 and $0.16 in FY2022.